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Left bundle branch block and coronary artery 
disease: Accuracy of dipyridamole thallium-201 
single-photon emission computed tomography in 
patients with exercise anteroseptal 
perfusion defects 
N. E. Lebtahi ,  MD, J. C. Stauffer,  MD, a n d  A. Bischof  Dela loye ,  MD 
Background.  Reduced septal or anteroseptal uptake of thallium-201 during exercise is 
frequently observed in patients with left bundle branch block (LBBB) even in the absence of left 
anterior descending (LAD) coronary artery disease. The purpose of this study was to evaluate 
prospectively the accuracy of dipyridamole 2°lTl single-photon emission computed tomography 
(SPECT) in detecting LAD coronary artery disease in patients with LBBB and septal or 
anteroseptal perfusion defects on exercise 2°lTI SPECT. 
• Methods and Results. Twelve consecutive patients (10 men and two women) with complete 
LBBB and septal or anteroseptal perfusion defects on exercise 2°lTl SPECT underwent 
dipyridamole 2°lTl SPECT. The delay between dipyridamole and exercise was 2 to 30 days. 
Coronary angiography was performed during this period in all patients. Six (50 %) of 12 patients 
with exercise perfusion defects showed normal perfusion after dipyridamole; all had normal 
coronary angiograms. The remaining six patients also had positive results of dipyridamole 
studies, two with moderate and four with severe septal or anteroseptal perfusion defects. 
Coronary angiography showed significant (>50%) LAD coronary artery stenosis in three 
patients; three patients with severe septal or anteroseptal perfusion defects after dipyridamole 
had normal coronary angiograms. Neither the evaluation of apical involvement nor the presence 
of dilated ventricles, decreased left ventricular ejection fraction, or wall motion abnormalities 
could help to identify (or explain) false-positive results. 
Conclusion. This study confirms that dipyridamole is more accurate than exercise in 
excluding LAD coronary artery disease. However, there are still false-positive results and the 
severity of the septal or anteroseptal perfusion defect does not add additional information to 
identify LAD coronary artery disease. Coronary angiography is thus necessary for positive 
dipyridamole study results to identify coronary artery disease as a major prognostic factor in 
patients with LBBB. (J Nucl Cardiol 1997;4:266-73.) 
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The high frequency of septal or anteroseptal perfu- 
sion defects on exercise scintigraphy in patients with left 
bundle branch block (LBBB) in the absence of left 
anterior descending (LAD) coronary artery disease has 
been well documented. 1-~3 Cumulative results (Table 1) 
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indicate that septal or anteroseptal perfusion defects were 
present in 73% of cases, whereas a significant LAD 
stenosis was shown by coronary angiography in only 
42%. Additional information in Table 1 indicates that the 
proportion of patients with LBBB and LAD coronary 
artery disease was only 38%. A proposed mechanism for 
the perfusion defects in the presence of normal coronary 
arteries is the occurrence of "relative hypoperfusion ''2,6 
caused by abnormal septal motion. Exercise by inducing 
tachycardia further shortens left ventricular diastole, 
which could explain the occurrence, as well as the 
reversibility, of the defects. Thus pharmacologic stress 
has been suggested to be a more accurate stimulus for the 
Journal of Nuclear Cardiology Lebtahi et al. 267 
Volume 4, Number 4;266-73 Accuracy of dipyridamole 2°1T1 SPECT 
Table  1. C u m u l a t i v e  resul t s  w i t h  e x e r c i s e  s c i n t i g r a p h y  in p a t i e n t s  w i t h  LBBB w h o  u n d e r w e n t  
c o r o n a r y  a n g i o g r a p h y  
No. LAD + 
Study No. patients* Tracer No. S or AS + No. TP (total) 
Hirzel et al. z 1984 19 Z°lTl 19 4 4 
Braat et al. 31 1985 24 2°lTI 7 6 11 
Huerta et al. 3 1987 11 ZmTI 8 0 0 
Rothbart et  al. 4 1987 22 ZmTl 16 5 7 
De Puey et  al. s 1988 14 ZmTl 12 3 4 
Burns et al. 6 1991 16 Z°~T1 12 5 6 
Matzer et al. 7 1991 44 Z°lT1 41 24 24 
Larcos et al. 8 1991 83 ZmTl 56 26 38 
La Canna et al. 9 1992 33 2°1TI 21 0 0 
Delonca et al. lo 1992 66 2°1T1 45 16 17 
Altehoefer  et al. zl 1993 9 99mTc-labeled sestamibi 3 2 5 
Knapp et  al.ZZ 1993 28 zo 1TI 26 l 5 16 
Knapp et al. z2 1993 37 99mTc-labeled sestamibi 34 14 15 
Ebersole et  al. 11 1993 11 99mTc-labeled sestamibi 8 2 3 
O'Keefe  et  al. 1 z 1993 31 ZO~Tl 20 11 15 
Vaduganathan et al. 13 1996 77 Z°lTl 57 29 33 
Total 525 385 (73%) 162 (42%) 197 (38%) 
S or AS+, Septal or anteroseptal perfusion defect; TP, true positive results (S or AS+ and LAD disease); LAD+, significant LAD coronary 
artery stenosis. 
*Only patients who underwent coronary angiography were considered. 
detect ion of  coronary  artery disease by myocard ia l  thal- 
l ium-201 imaging  in patients wi th  LBBB.  6,~2 28 W e  
studied prospec t ive ly  the va lue  o f  d ipyr idamole  in the 
identif icat ion o f  L A D  coronary  artery disease in patients 
with L B B B  and septal or anteroseptal  perfus ion defects 
on exerc ise  a°IT1 s ingle-photon emiss ion  computed  to- 
mography  (SPECT).  
METHODS 
Patients. Twelve consecutive patients (10 men and two 
women), aged 37 to 77 years (mean age 58 years), with 
complete LBBB and septal or anteroseptal perfusion defects on 
exercise 2roT1 SPECT underwent dipyridamole 2°1T1 SPECT 
within 1 month. All 12 patients underwent coronary angiogra- 
phy for clinical reasons during this period. Shown in Table 2 
are the clinical data of all patients. 
Exercise Protocol. Patients underwent a symptom-lim- 
ited Bruce protocol exercise test on a bicycle ergometer. At 
peak exercise, a weight-adjusted dose (range 2.5 to 3.5 mCi) of 
amT1 was administered intravenously and patients were encour- 
aged to continue exercising for 1 to 2 minutes. SPECT imaging 
was performed as soon as possible after the end of exercise and 
again 3 to 4 hours after the 2roT1 injection. 
Dipyridamole Protocol. Patients were advised to avoid 
food and caffeine-containing drinks for the 12 hours preceding 
the test. All patients had a 4-minute intravenous infusion of 
0.56 mg/kg dipyridamole. Cardiac rhythm was monitored 
continuously, and 12-lead electrocardiogram, blood pressure, 
and heart rate were obtained every 2 minutes during the test. 
Three minutes after the end of dipyridamole infusion, a 
weight-adjusted dose of 2roT1 (range 2.5 to 3.5 mCi) was 
administered and SPECT acquisition began 3 minutes later. 
Redistribution was imaged 3 to 4 hours after 2°1T1 injection. 
Z°lTi SPECT. 2°1T1SPECT imaging was performed with a 
single-head rotating gamma camera (Starcam; General Electric 
Co., Wilmington, Mass.), equiped with a low-energy, all- 
purpose collimator interfaced to a dedicated computer. Patients 
were placed in the supine position and 32 projections were 
obtained (step by step), 40 seconds each, through a 180-degree 
orbit beginning in a 45-degree right anterior oblique position 
and ending in a 45-degree left posterior oblique position. 
Images were stored in a 64 × 64 byte matrix. Tomographic 
reconstruction was performed with a filtered back-projection 
algorithm and a Hann filter. Oblique, orthogonal tomographic 
slices were used to reconstruct the left ventricle in the short- 
axis, horizontal long-axis, and vertical long-axis orientations. 
Anterior and septal walls were considered to represent the LAD 
coronary artery distribution and perfusion was scored qualita- 
tively by a consensus of three observers: 0 = severe perfusion 
defect (which corresponds to >50% of reduced uptake com- 
pared with normal region), 1 = moderate perfusion defect 
(>25% and <50% of reduced uptake compared with normal 
region), and 2 = normal perfusion. 
Coronary Angiography. After routine catheterization 
and premedication with diazepam, images were obtained in 
30-degree right anterior oblique views and 60-degree left 
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Table 2. Clinical da ta  
Obesity/  Previous Indication 
Patient Age (yr)/sex Prior MI Hypertension Diabetes hyperlipidemia CABG or PTCA 2°1TI SPECT 
! 61/M No No Yes No Yes Angina (at) 
2 50/M No No No No No Angina (at) 
3 64/M No Yes Yes No No LBBB only 
4 73/M No No No No Yes Angina (ty) 
5 43/M No No No No No Angina (ty) 
6 77/M No No Yes No No Angina (ty) 
7 67/M No Yes No No No Angina (ty) 
8 37/M No Yes No Hyperlipidernia No Angina (ty) 
9 58/F No No No Obesity No Angina (at) 
10 59/M Inferior Yes No No Yes Angina (ty) 
11 70/F No Yes No No Yes Angina (at) 
12 38/M No Yes No Hyperlipidemia No LBBB only 
ML Myocardial infarction; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; (at), atypical; (ty), 
typical. 
Table  3. Clinical, Z°lTl SPECT, and  angiographic  f indings 
Resting HR (n) Maximum HR (n) 
Development  of 
typical angina S/AS perfusion 
LAD 
Patient Exercise Dip Exercise Dip Exercise Dip Exercise Dip > 50% 
1 82 54 160 98 No 1 (PR) 2 No 
2 88 61 156 95 No 0 (PR) 2 No 
3 71 65 106 74 No 1 (RR) 0 (PR) No 
4 77 61 112 74 No 0 (F) 0 (PR) No 
5 63 60 170 83 No 0 (PR) 2 No 
6 102 (AF) 115 151 145 No 0 (F) 2 No 
7 70 70 132 91 Yes 0 (F) 0 (F) Yes (75%) 
8 60 65 180 95 No 1 (R) 2 No 
9 99 75 144 110 No 0 (R) 2 No 
10 70 82 132 104 Yes No 0 (PR) 1 (PR) Yes (700/o) 
11 62 56 95 78 No 1 (R) 1 (PR) Yes (75%) 
12 82 70 186 102 No 0 (PR) 0 (PR) No 
Hr, Heart rate; Dip, dipyridamole; S/AS, septal or anteroseptal; LAD >50%, significant LAD coronary artery stenosis; I, moderate peffusion 
defect; PR, partially reversible; 2, normal peffusion; 0, severe; RR, reverse redistribution; F, fixed perfusion defect; Ai r, atrial fibrillation; R, 
reversible. 
anterior oblique views (cranial and caudal orientations) and 
lateral views. Significant coronary artery stenosis was de- 
fined as a 50% or greater reduction in luminal diameter of 
any major coronary artery, primary branch, or bypass graft. 
A coronary artery was considered not to be compromised 
even in the face of significant native vessel disease if a 
patent bypass graft was inserted distal to the site of the 
lesion. Quantitative coronary angiographic analysis was 
performed with the ANCOR (Siemens-Elema, Solma, Swe- 
den) system. 19 
RESULTS 
Septa l  or  A n t e r o s e p t a l  Per fus ion  a n d  LAD Dis -  
e a s e .  Overall results are shown in Table 3. Six patients 
with exercise septal or anteroseptal perfusion defects had 
normal perfusion after dipyridamole (Figure 1); none of 
them had significant LAD coronary artery stenosis at 
coronary angiography. In the six patients who had only 
exercise perfusion defects, four defects were severe and 
two were moderate. The remaining six patients had 
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Figure 1. Patient 1. Septal perfusion defect is seen on exercise 2roT1 SPECT images (A). 
Dipyridamole 2mTl SPECT images of same patient (B) revealed normal perfusion. Coronary 
angiogram was normal. Rows 1, 3, and 5 fi-om top are initial images, and rows 2, 4, and 6 are 
redistribution images for both exercise and dipyridmnole. Vertical long-axis images are arranged 
from septal wall to lateral wall, horizontal long-axis images from anterior wall to inferior wall, and 
short-axis images from apex to base. 
Table 4.  Overall results in patients with septal or anteroseptal  perfusion defects  on both exercise and 
dipyr idamole  Z°lTl SPECT (n = 6) 
Exercise (n) Dip positive (n) 
Mod S/AS Severe S/AS Mod S/AS Severe S/AS Total 
defect defect defect defect (n) 
Patients 2 4 2 4 6 
Patients with LAD >50% 1 2 2 l 3 
Patients with normal LAD 1 2 0 3 3 
coronary arteries 
lMod, moderate; S/AS, septal or anteroseptal; Dip, dipyridamole. 
septal or anteroseptal perfusion defects on both exercise 
and dipyridamole 2°IT1 SPECT. Shown in Table 4 are the 
comparative results with regard to the severity of the 
perfusion defect. Three of six patients with positive 
dipyridamole study results had significant LAD coronary 
artery stenosis. 
Coronary arteriograms were normal in the remaining 
three patients who had severe septal or anteroseptal 
perfusion defects after dipyridamole (Figure 2). 
Severity o f  Coronary Artery Disease .  Three of 
12 patients had coronary artery disease. Two patients 
(patients 7 and 11) had double-vessel disease; both of 
them had multiple scintigraphic perfusion defects with 
exercise and also with dipyridamole. In addition to LAD 
coronary artery disease, patients 7 and 11 had, respec- 
tively, 70% and 100% stenosis of  the left circumflex 
coronary artery (also with the two grafts occluded for 
patient 11). The last patient had single-vessel disease. 
Clinical Data During Exercise and Dipyridam- 
ole .  Table 3 provides detailed clinical data during exer- 
cise and dipyridamole. Patients with normal dipyridam- 
ole images had a mean increase of heart rate of  77 -+ 30 
beats/min during exercise and 32 + 7 beats/min during 
dipyridamole infusion. Those with positive dipyridamole 
270 Lebtahi et al. Journal of Nuclear Cardiology 
Accuracy of dipyridamole 2°iT1 SPECT July]August 1997 
Figure 2. Dipyridamole (rows 1, 3, and 5 from top) and 
redistribution (rows 2, 4, and 6) 2roT1 SPECT images of patient 
12. Severe, partially reversible septal perfusion defect, includ- 
ing apex, is seen; there is also inferior perfusion defect. 
Coronary angiogram was normal. Images are arranged as in 
Figure 1. 
images had a mean increase of heart rate of 55 _+ 27 
beats/min during exercise and 19 _+ 8 beats/min during 
dipyridamole infusion. 
Analysis of False-Positive Results. Table 5 
shows further analysis of false-positive results with 
regard to presence or absence of apical involvement, 
dilated left ventricles, anterior or septal wall motion 
abnormalities, and the mean ejection fraction value. 
None of these parameters could help to identify or 
explain false-positive results. 
DISCUSSION 
Our results showed that six of 12 patients with 
LBBB and exercise septal or anterior perfusion defects 
had normal scintigraphic results after dipyridamole. All 
six patients with normal dipyridamole 2°iT1 SPECT 
results had normal coronary angiographic results. Only 
three of 12 patients with exercise septal or anteroseptal 
perfusion defects had LAD coronary artery disease. On 
the other hand, three of six patients with a positive 
dipyridamole study result had LAD coronary artery 
disease. These data indicate that dipyridamole Z°IT1 
SPECT was accurate in nine of 12 patients, whereas 
exercise was accurate in only three of 12 patients. 
Nevertheless, there are still false-positive results after 
dipyridamole with regard to the identification of patients 
with LBBB and underlying coronary artery disease. 
Moreover, only one of four patients with severe septal or 
anteroseptal perfusion defects after dipyridamole had 
LAD coronary artery disease, which indicates that the 
severity of the perfusion defect does not add additional 
information in identifying LAD coronary artery disease. 
In patient 7, exercise and dipyridamole 2°1T1 SPECT 
revealed a fixed anteroseptal perfusion defect with a 75% 
stenosis of the LAD, without a known previous myocar- 
dial infarction. However, ventriculography showed sep- 
tal dyskinesia, which suggests possible transient artery 
occlusion (non-Q wave myocardial infarction). 
In light of the mechanisms proposed to explain 
perfusion defects in LBBB, 2,6 their occurrence would 
be expected to be heart rate dependent. This was con- 
firmed by Vaduganathan et al., 13 who observed a rela- 
tion between heart rate and false-positive septal defects 
in the exercise group. Of interest was the much lower 
frequency of septal defects reported during dobuta- 
mine than during exercise. 13 They explain these find- 
ings by the much higher peak heart rate achieved during 
exercise than with dobutamine. However, the persistence 
of false-positive results after dipyridamole infusion con- 
firms that factors other than heart rate contribute to 
abnormal septal or anteroseptal perfusion in patients 
with LBBB. In our study, false-positive results after 
dipyridamole could not be explained by higher heart 
rate or a larger increase in heart rate compared with 
patients with normal dipyridamole images (Table 3). The 
study by Jukema et al. 15 also showed that septal dipyrid- 
amole perfusion defects were not dependent on heart 
rate. 
In our study neither the severity nor the extent of the 
perfusion defect could identify patients with underlying 
LAD coronary artery disease: six of eight patients with 
severe septal or anterior perfusion defects after exercise 
and three of four patients with severe defects after 
dipyridamole had normal coronary angiograms. With 
regard to the extent of the perfusion defect to the apex on 
exercise 2roT1 SPECT, we could not confirm the better 
diagnostic accuracy reported by Matzer et al.7; among 
five patients who had septal or anterior perfusion defects 
involving the apex on exercise 2roT1 SPECT, only one 
had LAD coronary artery disease. Our findings are 
supported by the results of Larcos et al., 8 who showed 
that apical extent of the exercise perfusion defect, al- 
though sensitive, was neither specific nor accurate in the 
identification of patients with coronary artery disease. 
Apical involvement was also of no help for dipyridamole 
in our study; among the three patients with false-positive 
findings for LAD coronary artery disease, two had 
perfusion defects involving the apex. The recent study of 
Vaduganathan et al. 13 reported the results of the largest 
series to date of patients with LBBB undergoing myo- 
cardial perfusion scintigraphy with three different mo- 
dalities of stress. They did not find value in the size of the 
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Table 5. Analysis of false-positive results 
False positive Other patients 
Exercise Dipyridamole Exercise Dipyridamole 
( n =  9) ( n =  3) (n = 3) ( n =  9) 
Apical involvement (n) 
Dilated left ventricle (n) 
Mean ejection fraction (%) 
Anterior or septal wall 
motion abnormalities 
4/9 2/3 1/3 1/9 
2/9 0/3 1/3 3/9 
54 54 60 57 
4/9 1/3 3/3 6/9 
perfusion defect or the involvement of the anterior wall, 
the apex, or another territory in differentiating true from 
false-positive cases during exercise. They also reported a 
higher left ventricular ejection fraction in the subgroup 
of patients who exercised and had false-positive scan 
responses compared with those with true positive scan 
results. 
Hodge et al. 2° suggested that dilated left ventricles 
may be responsible for false-positive results in patients 
with LBBB. In our study, only two of nine patients with 
false-positive results after exercise and none of three 
patients with false-positive results after dipyridamole 
had dilated left ventricles. Therefore we could not 
confirm this hypothesis. 
Our results are in agreement with those of previous 
studies, 6,12-18 which showed that septal or anteroseptal 
perfusion defects in patients with LBBB are less frequent 
with pharmacologic stress, thereby improving the spec- 
ificity of thallium scintigraphy in those patients. Few 
studies, however, compared dipyridamole (or adenosine) 
and exercise in the same patients. In this study, only 
patients with abnormal septal or anteroseptal perfusion 
on exercise 2°1T1 SPECT underwent dipyridamole stress, 
whereas in the other comparative studies 6,~~4 patients 
without perfusion defects on the exercise study also 
underwent dipyridamole scintigraphy. Because the limi- 
tation with exercise is the high number of false-positive 
results, we chose to evaluate dipyridamole in patients 
with positive exercise scintigrams. Analysis in our study 
of clinical data, results of 2°1T1 SPECT in terms of 
severity and extent of perfusion defect or dilated left 
ventricle, and ventriculographic and coronary arterio- 
graphic findings could not explain the false-positive 
scintigraphic results or help to identify patients with 
underlying coronary artery disease. 
There are several hypotheses to explain the mecha- 
nism for abnormal perfusion in LBBB. Grines et al. 23 
reported that altered electrical activation as a result of 
LBBB is responsible for global ventricular abnormalities 
that could lead to abnormal septal motion and abnormal 
left ventricular ejection. The occurrence of "relative 
hypoperfusion" caused by the abnormal septal motion 
that could cause a prolonged compression of the septal 
arteries has been proposed by Hirzel et al. 2 Another 
explanation for this relative hypoperfusion has been 
proposed by Bums et al. 6 They postulated that in patients 
with LBBB the septum contracts in early systole with 
low tension to overcome right ventricular rather than left 
ventricular outflow resistance as it occurs with normal 
conduction; therefore the septal wall will receive less 
coronary flow as a result of coronary autoregulation. Ono 
et al. 24 used an in vivo animal model to determine 
whether LBBB itself induces abnormal myocardial per- 
fusion and ischemia. They demonstrated that during 
LBBB the mean septal intramyocardial pressure in- 
creased significantly in the T D phase, which may result in 
reduced myocardial perfusion in the septum. Neverthe- 
less, they did not observe indirect signs of nayocardial 
ischemia such as increased septal glucose uptake or 
lactate production. In view of these data, perfusion of the 
septal or anteroseptal territories may be reduced for 
functional rather than anatomic reasons and the so-called 
false-positive 2°1T1 study results might well demonstrate 
relative hypoperfusion. 
The occurrence of septal or anteroseptal perfusion 
defects is obviously not restricted to the use of 2mTl. 
Results are somewhat conflicting on the occurrence of 
septal or anterior defects with exercise sestamibi. Alte- 
hoefer et al. 21 postulated that 99mTc-labeled sestamibi 
scintigraphy could be more accurate for the detection of 
coronary artery disease in patients with LBBB because 
most of these patients (55%) revealed normal septal 
uptake. However, the findings of Knapp et al. 22 differ 
because they described a septal defect (reversible or not) 
on 99mTc-labeled sestamibi scintigraphy in 34 (91.8%) of 
37 patients. In both studies the authors speculated that 
the reversibility of the defect could identify patients with 
coronary artery disease. Nevertheless, false-positive re- 
sults with sestamibi according to the criterion of revers- 
ibility have been described. 25,26 Another study 1~ revealed 
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the conflicting results of 99mTc-labeled sestamibi scintig- 
raphy in LBBB. In this study, Ebersole et al., 1~ who 
compared exercise and adenosine stress, pointed out that 
the specificity in the territory of the LAD coronary artery 
was only 25% with exercise, whereas that for adenosine 
was 87.5%. Moreover, in their study, all but one patient 
who had false-positive results with exercise had a revers- 
ible defect, which confirms that the criterion of revers- 
ibility could not help to identify patients with LBBB and 
underlying coronary artery disease. They also conclude 
by using 99mTc-labeled sestamibi scintigraphy to the 
improved specificity of pharmacologic stress compared 
with exercise. 
Limitation of  the  Method.  It can be argued that 
tomographic analysis in our study was qualitative. How- 
ever, very good correlations between visual and quanti- 
tative analysis have been described. The superiority of 
the quantitative analysis has not been proved clearly, and 
there is no significant difference (statistically significant) 
between the two modalities of analysis. 27 In fact, the 
problem with myocardial scintigraphy in patients with 
LBBB is the high frequency of perfusion defects in the 
absence of LAD artery disease, which means that the 
specificity of thallium scintigraphy in detection of LAD 
disease is of concern. It is known that quantitative 
analysis is equivalent to or lower than visual analysis in 
this setting. 27-3° Moreover, even with quantitative anal- 
ysis, several studies 4-6,8,12,~3 reported the low specificity 
of exercise 2°1T1 scintigraphy in detecting LAD coronary 
artery disease in patients with LBBB. Last, in our study, 
six of eight and three of four patients with severe 
perfusion defects (which means clearly positive results) 
after, respectively, exercise and dipyridamole had nor- 
mal coronary arteries. Quantitative analysis cannot help 
increase diagnostic accuracy in these patients. 
Conclus ion.  In view of the cumulative results of 
exercise scintigraphy and the conflicting results with 
other alternatives (apical involvement and exercise ses- 
tamibi), pharmacologic stress by either dipyridamole or 
adenosine seems the preferred choice to exercise scin- 
tigraphy in patients with LBBB, by reducing the number 
of so-called false-positive results. In case of normal 
perfusion with dipyridamole, coronary artery disease can 
reasonably be excluded and there is no real indication to 
perform coronary angiography; therefore the number of 
coronary angiograms in patients with LBBB may be 
reduced by use of pharmacologic stress. However, even 
severe septal or anteroseptal perfusion defects on dipy- 
ridamole studies may occur in the absence of LAD 
coronary artery disease. The presence or absence of 
apical involvement, dilated left ventricles, decreased left 
ventricular ejection fraction, or wall motion abnormali- 
ties could not help in the identification of patients with 
false-positive results. Coronary angiography is thus still 
indicated in studies with positive results to identify 
patients with underlying coronary artery disease, a major 
prognostic factor in patients with LBBB. 
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